Xention Limited Builds Team with Appointment of Chief Medical Officer
Xention Ltd. announced the appointment of Dr Patrick Round as Chief Medical Officer and Head of Development.
Dr Round has broad and substantial experience in development in both biotech and pharma, most notably as Senior Vice President at Cambridge Antibody Technology (CAT) where he was responsible for all aspects of development including manufacturing, process development, quality, regulatory, clinical development and project management. He was a member of the CAT leadership team responsible for the day to day running of the company and chaired the product steering committee responsible for project governance and oversight of the discovery and development interface.
Previously, Dr Round was Director of Development at Celltech R&D, Director of Clinical Development at Glaxo Wellcome and clinical project manager at Novo Nordisk Pharmaceuticals. He has also served as Chief Medical Officer at Phoqus Pharmaceuticals.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
